Immunity to chlamydia trachomatis

Journal of Infectious Diseases

Volumn 207, Issue 12, 2013, Pages 1796-1797

  Brunham, Robert C ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

chlamydia; epidemiology; immunity

Indexed keywords

AZITHROMYCIN; GAMMA INTERFERON; IMMUNOGLOBULIN A ANTIBODY;

BACTERIAL CLEARANCE; BACTERIAL SHEDDING; CD4+ T LYMPHOCYTE; CHLAMYDIA TRACHOMATIS; CHLAMYDIASIS; CYTOKINE RELEASE; EDITORIAL; HUMAN; IMMUNE RESPONSE; IMMUNITY; NONHUMAN; PRIORITY JOURNAL; REINFECTION; SEXUALLY TRANSMITTED DISEASE;

CHLAMYDIA; EPIDEMIOLOGY; IMMUNITY;

ANTI-BACTERIAL AGENTS; CHLAMYDIA INFECTIONS; CHLAMYDIA TRACHOMATIS; FEMALE; GENITAL DISEASES, FEMALE; HUMANS;

EID: 84877953686     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1093/infdis/jit095     Document Type: Editorial

References (15)

1. Geisler WM, Lensing SY, Press CG, Hook EW III. Spontaneous resolution of genital Chlamydia trachomatis infection in women and protection from reinfection. J Infect Dis 2013; 207:1850-6.
2. Molano M, Meijer CJ, Weiderpass E, et al. The natural course of Chlamydia trachomatis infection in asymptomatic Colombian women: a 5-year follow-up study. J Infect Dis 2005; 191:907-16.
3. Cohen CR, Koochesfahani KM, Meier AS, et al. Immunoepidemiologic profile of Chlamydia trachomatis infection: importance of heat-shock protein 60 and interferon-gamma. J Infect Dis 2005; 192:591-9.
4. Brunham RC, Kimani J, Bwayo J, et al. The epidemiology of Chlamydia trachomatis within a sexually transmitted diseases core group. J Infect Dis 1996; 173:950-6.
5. Brunham RC, Kuo CC, Cles L, Holmes KK. Correlation of host immune response with quantitative recovery of Chlamydia trachomatis from the human endocervix. Infect Immun 1983; 39:1491-4.
6. Farris CM, Morrison RP. Vaccination against Chlamydia genital infection utilizing the murine C. muridarum model. Infect Immun 2011; 79:986-96.
7. Moore T, Ekworomadu CO, Eko FO, et al. Fc receptor-mediated antibody regulation of T cell immunity against intracellular pathogens. J Infect Dis 2003; 188:617-24.
8. Farris CM, Morrison SG, Morrison RP. CD4 + T cells and antibody are required for optimal major outer membrane protein vaccine-induced immunity to Chlamydia muridarum genital infection. Infect Immun 2010; 78:4374-83.
9. Brunham RC, Pourbohloul B, Mak S, White RRekart ML. The unexpected impact of a Chlamydia trachomatis infection control program on susceptibility to reinfection. J Infect Dis 2005; 192:1836-44.
10. Rekart ML, Gilbert M, Meza R, et al. Chlamydia public health programs and the epidemiology of pelvic inflammatory disease and ectopic pregnancy. J Infect Dis 2013; 207: 30-8.
11. Su H, Morrison R, Messer R, Whitmire W, Hughes S, Caldwell HD. The effect of doxy-cycline treatment on the development of protective immunity in a murine model of chlamydial genital infection. J Infect Dis 1999; 180:1252-8.
12. Williams MA, Bevan MJ. Shortening the infectious period does not alter expansion of CD8 T cells but diminishes their capacity to differentiate into memory cells. J Immunol 2004; 173:6694-702.
13. Karunakaran KP, Rey-Ladino J, Stoynov N, et al. Immunoproteomic discovery of novel T cell antigens from the obligate intracellular pathogen Chlamydia. J Immunol 2008; 180:2459-65.
14. Wang J, Zhang Y, Lu C, Lei L, Yu P, Zhong G. A genome-wide profiling of the humoral immune response to Chlamydia trachomatis infection reveals vaccine candidate antigens expressed in humans. J Immunol 2010; 185:1670-80.
15. Finco O, Frigimelica E, Buricchi F, et al. Approach to discover T-and B-cell antigens of intracellular pathogens applied to the design of Chlamydia trachomatis vaccines. Proc Natl Acad Sci U S A 2011; 108: 9969-74.